The field continues to evolve with advancements in technology, genetics, and pharmacology.
Selective Serotonin Reuptake Inhibitors (SSRIs) like fluoxetine or tricyclic antidepressants (TCAs) like clomipramine are frequently prescribed for severe separation anxiety, compulsive disorders, and territorial aggression. These medications do not sedate the animal; instead, they lower the emotional baseline of panic so that behavior modification protocols can actually take effect. 5. Welfare Implications in Production and Shelter Settings
This led to a culture of "restrain and treat." A fractious cat was scruffed. A fearful dog was muzzled and pinned. The prevailing wisdom was that the medical necessity of the treatment outweighed the psychological cost to the animal. The field continues to evolve with advancements in
Repetitive behaviors, such as a horse cribbing or a dog obsessively licking its paws (acral lick dermatitis), can stem from gastrointestinal discomfort, neurological conditions, or severe environmental stress.
: Drugs like gabapentin or trazodone are given prior to veterinary visits or thunderstorms to manage acute anxiety. The prevailing wisdom was that the medical necessity
For decades, the popular image of veterinary medicine was straightforward: a kind doctor in a white coat diagnoses a physical ailment—a broken bone, an infection, a tumor—and prescribes a cure. The animal’s mind, its emotions, and its innate behavioral patterns were often considered secondary, almost an afterthought. But in the 21st century, a quiet revolution has taken place in clinics, barns, and laboratories around the world. The fields of and veterinary science have become inseparable partners.
: Diagnosis and treatment of disorders like aggression, inappropriate elimination, and anxiety using both behavior modification and pharmacologic therapy. Livestock Management loss of litter box training
Subtle shifts—like hiding, loss of litter box training, or excessive licking—can be the first signs of hyperthyroidism, neurological disorders, or GI disease.
The field continues to evolve with advancements in technology, genetics, and pharmacology.
The turning point came with two realizations: